6
MERK0212.TXT

MERK
Merck Indonesia Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Dec-2002
Fiscal Year Ends            : Dec
Months Covered in Income St : 12

Summary of Balance Sheet
  Receivables               :      37,448,482.00
  Inventories               :      46,920,181.00
  Current Assets            :     127,334,481.00
  Fixed Assets              :      29,471,292.00
  Other Asstes              :       1,095,096.00
  Total Assets              :     172,336,151.00
  Current Liabilities       :      22,764,749.00
  Longterm Liabiities       :         325,306.00
  Total Liabilities         :      23,090,055.00
  Authorized                :          22,400.00
  Paid-up Capital           :      22,400,000.00
  Par Value                 :               1000
  Paid-up Capital Shares    :          22,400.00
  Retained Earnings         :     107,978,552.00
  Total Equity              :     149,242,804.00
  Minority Interest         :           3,292.00

Summary of Income Statement
  Total Sales               :     220,918,142.00
  Cost of Good Sold         :      88,545,687.00
  Gross Profit              :     132,372,455.00
  Operating Profit          :      51,153,672.00
  Other Income              :       3,301,474.00
  Eearning Before Tax       :      54,455,146.00
  Tax                       :      17,026,897.00
  Net Income                :      37,428,795.00
  Closing Price             :          10,000.00

Per Share Data (Rp)
  Eps                       :           1,670.93
  Book Value                :           6,662.63

Financial Ratios
  Debt Equity Ratio (X)     :                .15
  Roa (%)                   :              21.72
  Roe (%)                   :              25.08
  Npm (%)                   :              16.94
  Opm (%)                   :              23.16

Cash Flow
  CF from Operating Activities                        :      28,286,387.00
  CF from Investing Activities                        :     -14,483,914.00
  CF from Financing Activities                        :      -8,920,663.00
  Net Increase in Cash & Cash Equivalent              :       4,881,810.00
  Cash & Cash Equivalent at The Beginning of The Year :      34,013,078.00
  Cash & Cash Equivalent at The End of The Year       :      38,559,853.00

 
 
 
